http://www.medicalnewstoday.com/rss/lung_cancer.xmlhttp://swiv.eu/lung-cancer-news-from-medical-news-today_177.xml Add to your feed
16.04.2012 10:00
Previous research has shown that Asian patients with lung cancer are more likely to harbor epidermal growth factor receptor (EGFR) mutations. Furthermore, Asian patients with lung cancer are more likely to be non-smokers than Western patients with lung cancer...
Screening for lung cancer with low dose CT scans has been shown to save lives. However, research shows that when CT scans reveal nodules in the lungs, they are not cancerous 96 percent of the time. As a result, scientists are looking for ways to more accurately make a diagnosis. One way is by using a CT guided transthoracic fine needle aspiration...
Scientist say there is an urgent need for research into all aspects of follow-up care in lung cancer. The study presented in the May 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology focused on different follow-up strategies for patients with lung cancer...
13.04.2012 13:00
Cases of lung cancer among women in the UK continue to rise, according to new figures released by Cancer Research UK on Friday. The leading charity says the rate of lung cancer among women in the UK has risen from 22.2 in every 100,000 women in 1975, to 39.3 today...
13.04.2012 10:00
In a scientific paper published in the journal PLoS ONE, researchers from SomaLogic and the University of Washington in Seattle describe the first application of the SOMAscanTM proteomic assay technology to tissue samples...
12.04.2012 22:00
A study published in the April issue of Health Affairs reveals that thousands of lives could be saved at a fairly low cost if commercial insurers routinely covered lung cancer screening. In the United States, lung cancer is the leading cause of cancer deaths each year - killing over 150,000 individuals...
12.04.2012 10:00
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have shown that breast cancer cells that metastasize to the lung express a higher level of the protein peroxiredoxin 2 (PRDX2). The study suggests that the modulation of the levels of this protein could be a new therapeutic strategy to prevent lung metastases...
12.04.2012 01:00
A new study, published online ahead of print publication in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine, shows that cognitive and psychiatric impairments are common amongst long-term survivors of acute lung injury (ALI), and these impairments can be evaluated by using a telephone-based test battery. Leading researcher, Dr. Mark E...
11.04.2012 12:00
Lung cancer is the most lethal cancer in the United States. According to the National Cancer Institute, lung cancer causes more than 150,000 deaths annually and has a survival rate of 16 percent. More Americans die of lung cancer each year than of cervical, breast, colon and prostate cancers combined...
10.04.2012 10:00
Men experience a marked drop in their testosterone levels when taking a targeted therapy to control a specific type of lung cancer. That's according to a University of Colorado Cancer Center study published in the April issue of Cancer, the official journal of the American Cancer Society...
09.04.2012 10:00
Long-term follow-up of a phase II clinical trial showed encouraging survival in some patients with stage 3B/4 non-small cell lung cancer treated with belagenpumatucel-L, a therapeutic vaccine. The findings were presented at the AACR Annual Meeting 2012. "This is a novel immunotherapy that appears to show unusually long survival in some patients," said Lyudmila Bazhenova, M.D...
05.04.2012 11:00
The hormone estrogen may help promote lung cancer - including compounding the effects of tobacco smoke on the disease - pointing towards potential new therapies that target the hormone metabolism, according to new research presented at the AACR Annual Meeting 2012 by scientists at Fox Chase Cancer Center in Philadelphia...
05.04.2012 10:00
A combination of nab-paclitaxel and carboplatin for the treatment of non-small cell lung cancer may be a promising option for patients ineligible for treatment with bevacizumab, according to data presented at the AACR Annual Meeting 2012, March 31 - April 4...
03.04.2012 10:00
New research shows it may be no accident when doctors observe how patients suffering from both breast cancer and arthritis seem to have more aggressive cancer. However, the new-found interaction between the two diseases may also suggest a possible treatment...
A new study led by researchers at Mount Sinai School of Medicine indicates that CT scans are more effective than traditional lung cancer detection methods at identifying aggressive lung cancers in their most treatable stages...
29.03.2012 11:00
Growth rates of lung cancers found by annual rounds of computed tomography (CT) screening are important for determining the usefulness and frequency of screening, as well as for determining the treatment...
27.03.2012 10:00
Studying the role of social stigma in depression for lung cancer patients, researchers at Moffitt Cancer Center in Tampa, Fla., have found that depression can be heightened by a lung cancer patient's sense of social rejection, internalized shame and social isolation. These factors may contribute to depression at rates higher than experienced by patients with other kinds of cancer...
26.03.2012 11:00
New imaging parameters rein in incremental radiation dose from potentially life-saving CT-guided biopsy of lung nodules to reduce patients' overall exposure. New guidelines for CT-guided biopsies of lung nodules significantly reduce radiation exposure allowing individuals the benefit of the procedure, which may cut down on overall lung cancer deaths...
26.03.2012 10:00
Experimenting with cells in culture, researchers at the Johns Hopkins Kimmel Cancer Center have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The drugs, azacitidine (AZA) and decitabine (DAC), are epigenetic-targeted drugs and work to correct cancer-causing alterations that modify DNA...
21.03.2012 10:00
Non-small cell lung cancer (NSCLC), the most common form of lung cancer, is usually treated with surgery and chemotherapy. However, a small group of patients can also be helped by treatment with tyrosine kinase inhibitors (TKI)...
19.03.2012 19:00
According to a study published March 14 in the Journal of the National Cancer Institute, even though there has been a significant decline in smoking and lung cancer mortality in the United States, more deaths could have been prevented had all smoking ceased following the 1964 Surgeon General's Report. Since the mid 1950's, the number of smokers in the U.S...
19.03.2012 09:00
Researchers found that CYFRA and change in levels of CYFRA were found to be reliable markers for response to chemotherapy for non-small cell lung cancer (NSCLC) in a study of 88 patients...
A panel of serum biomarkers could help predict the level of lung cancer risk in high-risk patients, offering doctors an option before proceeding with a biopsy. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology shows that a panel of 10 serum protein biomarkers could help in the lung cancer diagnosis...
Retinoic acid (vitamin A) and steroids are hormones found in our body that protect against oxidative stress, reduce inflammation and are involved in cellular differentiation processes. One of the characteristics of tumors is that their cells have lost the ability to differentiate; therefore these hormones have useful properties to prevent cancer...
16.03.2012 09:00
Although changing smoking behaviors have had a major impact on lung cancer mortality in the U.S., the numbers of lung cancer deaths averted are only a small fraction of deaths that could have been avoided had all smoking ceased following the 1964 Surgeon General's Report...
05.03.2012 10:00
Heavy diesel exhaust (DE) exposure in humans may increase the risk of dying from lung cancer, according to two papers released March 2nd by the Journal of the National Cancer Institute. Starting in the 1980s, studies have investigated a possible causal relationship between exposure to diesel exhaust and lung cancer...
01.03.2012 09:00
Often faced with overwhelming anxiety, patients newly diagnosed with lung cancer can find themselves in distress, and new research recommends nurses play a key role in alleviating concerns, leading to a better quality of life for patients...
Researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues in California have found that the XL888 inhibitor can prevent resistance to the chemotherapy drug vemurafenib, commonly used for treating patients with melanoma. Vemurafenib resistance is characterized by a diminished apoptosis (programmed cancer cell death) response...
29.02.2012 10:00
New figures published today (Wednesday) estimate that there will be nearly 1.3 million deaths from cancer in 2012 in the European Union (EU) - 717,398 men and 565,703 women. Although the actual numbers have increased, the rate (age-standardised per 100,000 population) of people who die from the disease continues to decline...
22.02.2012 09:00
A simple blood test is being developed by researchers at Ben-Gurion University of the Negev (BGU) and Soroka University Medical Center in Beer-Sheva, Israel that may provide early detection of many types of cancer. Prof. Kapelushnik of BGU's Faculty of Health Sciences and his team developed a device that illuminates cancer cells with less than a teaspoon of blood...
Mitochondria, tiny structures within each cell that regulate metabolism and energy use, may be a promising new target for cancer therapy, according to a new study. Manipulation of two biochemical signals that regulate the numbers of mitochondria in cells could shrink human lung cancers transplanted into mice, a team of Chicago researchers report in the journal FASEB...
18.02.2012 09:00
Drugs targeting an enzyme involved in inflammation might offer a new avenue for treating certain lung cancers, according to a new study by scientists at the Salk Institute for Biological Studies...
17.02.2012 10:00
As oncologists already know and newly diagnosed lung cancer patients learn, the kind of treatment given to patients is increasingly becoming dependent on the specific gene mutation present in the cancer...
15.02.2012 10:00
The use of an injectable, clot-preventing drug known as Low Molecular Weight Heparin to treat patients with advanced cancer complicated by blood clots increased steadily between 2000 and 2007, according to a new study published in The Oncologist, funded by the National Cancer Institute and led by Kaiser Permanente Colorado...
13.02.2012 11:00
Researchers from Mount Sinai School of Medicine have found that post-operative radiation therapy (PORT), a controversial yet frequently administered treatment for lung cancer, may not prolong life in older people with locally advanced disease. The findings appear in the February 13 online edition of Cancer, a peer-reviewed journal of the American Cancer Society...
13.02.2012 09:00
Researchers at Moffitt Cancer Center in Tampa, Fla., have discovered that the immune response regulator IKBKE (serine/threonine kinase) plays two roles in tobacco-related non-small cell lung cancers. Tobacco carcinogens induce IKBKE and, in turn, IKBKE induces chemotherapy resistance. The study was published in a recent issue of Oncogene...
12.02.2012 09:00
The vast majority of patients with incurable lung or colorectal cancer talk with a physician about their options for care at the end of life, but often not until late in the course of their illness, according to a new study by Dana-Farber Cancer Institute investigators published in the Annals of Internal Medicine...
07.02.2012 09:00
Scientists from The Scripps Research Institute, Scripps Health, and collaborating cancer physicians have successfully demonstrated the effectiveness of an advanced blood test for detecting and analyzing circulating tumor cells (CTCs) - breakaway cells from patients' solid tumors - from cancer patients...
Different kinds of lung cancer behave in different ways, suggesting they are fundamentally different diseases. According to a University of Colorado Cancer Center study published in Cancer, the official journal of the American Cancer Society, different subgroups of non-small cell lung cancer (NSCLC) show distinct patterns of spread in the body...
05.02.2012 09:00
Combination drug therapy may be needed to combat non-small cell lung cancer (NSCLC), according to a study by the Translational Genomics Research Institute (TGen) and Van Andel Research Institute (VARI). The study, "STAT3 is Activated by JAK2 Independent of Key Oncogenic Driver Mutation in Non-Small Cell Lung Carcinoma," was published online by the Public Library of Science (PLoS) ONE...
02.02.2012 10:00
A report from investigators at the Massachusetts General Hospital (MGH) Cancer Center has defined the role of a recently identified gene abnormality in a deadly form of lung cancer. Tumors driven by rearrangements in the ROS1 gene represent 1 to 2 percent of non-small-cell lung cancers (NSCLC), the leading cause of cancer death in the U.S...
ONCOLOGY: Answers to age-old questions surrounding fat cell cancer Myxoid round cell liposarcoma (MRCLS) is a cancerous tumor that typically arises in deep fat tissues of the limbs or abdomen. It was shown almost 20 years ago to be characterized by a chromosomal change that generates a fusion protein known as TLS:CHOP...
31.01.2012 09:00
Cancer is one of the most common causes of death in humans. The conventional cancer therapies include surgery, radiotherapy, chemotherapy, and targeting therapies, which are intended to directly destroy and eliminate tumor cells. These treatments often fail, resulting in tumor metastasis and recurrence. Therefore, there is a critical need for novel cancer therapies...
According to a recent study, there is a new mechanism of drug release using 3D superhydrophobic materials that utilizes air as a removable barrier to control the rate at which drug is released. The study was electronically published in the Journal of the American Chemical Society...
27.01.2012 21:00
An assay which measures the activity of 14 genes in lung cancer tumors can accurately predict who will respond well to surgery and who will probably die within five years, researchers from the University of California, San Francisco, reported in The Lancet...
24.01.2012 19:00
According to a study published January 23 online in Cancer, many smokers do not drop the habit after being diagnosed with colorectal or lung cancer. The study by Elyse R. Ph.D., M.P.H.and her team at Massachusetts General Hospital, Boston involved 3,063 patients with colorectal cancer and 2,456 with lung cancer. The patients were seen at the time of diagnosis, and also five months later...
24.01.2012 13:00
A new analysis has found that a substantial number of lung and colorectal cancer patients continue to smoke after being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study provides valuable information on which cancer patients might need help to quit smoking...
23.01.2012 09:00
New research published in Nature Medicine indicates that targeted drugs such as gefitinib might more effectively treat non-small cell lung cancer if they could be combined with agents that block certain microRNAs. The study was led by investigators with the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J...
20.01.2012 10:00
Scientists from the University of Colorado Cancer Center have once again advanced the treatment of a specific kind of lung cancer. The team has documented how anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC) becomes resistant to a drug targeting the abnormal protein in the cancer...
19.01.2012 11:00
Tuberculosis (TB) has been suspected to increase a person's risk of lung cancer because the pulmonary inflammation and fibrosis can induce genetic damage. However, direct evidence of specific genetic changes and the disease have not been extensively reported...
12.01.2012 19:00
According to an investigation published in the recent issue of the Journal of the National Cancer Institute, researchers at Moffitt Cancer Center in Tampa, Florida have discovered that a malignancy-risk gene signature created for breast cancer has predictive and prognostic value for individuals suffering with early stage non-small cell lung cancer (NSCLC)...
11.01.2012 11:00
Smoking may be associated with the development of molecular features of cancer in the large airway epithelium. In the small airway epithelium, molecular cancerization is associated with development of chronic obstructive pulmonary disease, according to recent data...
The investigational drug ganetespib, a synthetic second-generation Hsp90 inhibitor, slowed the growth of cancer cells taken from non-small cell lung cancer tumors with a mutation in the KRAS gene. The drug was even more active when combined with traditional lung cancer treatments and other investigational targeted therapies, according to preclinical study data. David A. Proia, Ph.D...
10.01.2012 12:00
Researchers have developed a method to analyze circulating tumor cells in the blood of patients with non-small cell lung cancer. This method, which can analyze a sample size as small as three cells, may allow clinicians to track cancer progress and treatments and could help them develop new therapies...
10.01.2012 11:00
Researchers have begun to identify which mutations and pathway changes lead to lung cancer in never-smokers - a first step in developing potential therapeutic targets. Never-smokers (defined as an individual who smoked fewer than 100 cigarettes in his or her lifetime) are estimated to account for 10 percent of lung cancer cases...
Multicentric carcinogenesis with the same genetic mutation appears to occur in lung adenocarcinoma, according to data presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy and Personalized Medicine, held Jan. 8-11, 2012...
A combination of drugs that target estrogen production significantly reduced the number of tobacco carcinogen-induced lung tumors in mice, according to results from a preclinical study. "Antiestrogens have been shown to prevent breast cancer in some women," said Jill M. Siegfried, Ph.D...
Sorafenib was effective in patients with non-small cell lung cancer and a KRAS mutation, but survival rates were reportedly "unsatisfactory," according to data presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy and Personalized Medicine, held Jan. 8-11, 2012...
10.01.2012 10:00
A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute...
Use of statins may influence susceptibility to or the progression of interstitial lung disease (ILD) in smokers, according to a new study...
06.01.2012 19:00
Data assessing custirsen (OGX-011/TV-1011), an investigational compound, in individuals with advanced non-small cell lung cancer (NSCLC) were published online in the January 2012 issue of the Journal of Thoracic Oncology, OncoGenex Pharmaceuticals, Inc. announced January 4th...
04.01.2012 18:00
Each year in the U.S., lung cancer kills more individuals than prostate, colon, and breast cancers combined. Often the disease goes undetected until it has reached an advanced and more difficult-to-treat stage. At present the only method to detect lung cancer are biopsies, which are highly involved and invasive for patients...
03.01.2012 10:00
Smoking is a well-known risk factor for lung cancer, but nearly 25% of all lung cancer patients have never smoked. In a study published online in Genome Research (http://www.genome.org), researchers have identified a previously unknown gene fusion event that could explain a significant proportion of lung cancer cases in never-smokers, and might serve as a target for new therapies...
01.01.2012 10:00
Lung Cancer Alliance (LCA) President Laurie Fenton-Ambrose predicted that because of major breakthroughs this year in screening, treatment and research, 2011 will be defined as the turning point year for lung cancer...
Lung cancer takes a heavy toll, contributing to more cancer deaths in the United States each year than breast, prostate and colon cancers combined. Contributing to this poor prognosis is the fact that lung cancer often goes undetected until the disease has reached an advanced and more difficult-to-treat stage...
24.12.2011 10:00
Tecnalia, through the Interreg project Medisen, is contributing to develop biosensors capable of detecting the presence of tumour markers of lung cancer in exhaled breath...
20.12.2011 10:00
The cancer-causing potential of fetal exposure to carcinogens can vary substantially, a recent study suggests, causing different types of problems much later in life depending on the stage of pregnancy when the fetus is exposed. The research sheds further light on the way in which toxic damage early in life can later manifest themselves as cancer, due to "epigenetic" changes in cells...
Scientists may have a way to double the efficacy and reduce the side effects of radiation therapy. Georgia Health Sciences University scientists have devised a way to reduce lung cancer cells' ability to repair the lethal double-strand DNA breaks caused by radiation therapy. "Radiation is a great therapy - the problem is the side effects," said Dr. William S...
19.12.2011 10:00
Metabolomx, a diagnostic company focused on the detection of the metabolomics signature of cancer from exhaled breath, announces publication of results from the first clinical study demonstrating a breath test that can both detect lung cancer and differentiate between types of lung cancer in humans. This seminal study, conducted at the Cleveland Clinic and led by Dr...
Ohio State University researchers have discovered a hereditary cancer syndrome that predisposes certain people to a melanoma of the eye, along with lung cancer, brain cancer and possibly other types of cancer. The hereditary cancer syndrome is caused by an inherited mutation in a gene called BAP1, researchers say...
The International Association for the Study of Lung Cancer (IASLC) has taken a proactive role in advancing discussions with the international lung cancer community on how we should take lung cancer screening forward...
18.12.2011 10:00
The research team at Lyon has developed an animal model carrying a mutation of the DCC gene. Mice carrying the mutation develop tumours, because this gene can no longer induce the death of the cancer cells. This discovery could lead to the development of a new targeted cancer treatment that aims to reactivate the dying of cancer cells...
15.12.2011 10:00
Molecular markers found in cancer cells that have spread from a primary tumor to a limited number of distant sites can help physicians predict which patients with metastatic cancer will benefit from aggressive, targeted radiation therapy...
03.12.2011 10:00
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the cobas EGFR Mutation Test is now CE marked for commercial availability in Europe and other countries that recognize CE mark...
02.12.2011 11:00
22.11.2011 11:00
A new type of "triggered imaging" technology enables University of Alabama at Birmingham physicians to better target tumors during radiosurgery and lessens the risk of injury to surrounding lung tissue. Radiosurgery is a focused, highly targeted, high dose of radiation treatment typically taking three to five sessions, as opposed to 25 to 30 sessions for conventional radiation therapy...
20.11.2011 10:00
The metabolism of lung cancer patients is different than the metabolism of healthy people. And so the molecules that make up cancer patients' exhaled breath are different too. A new device pioneered at the University of Colorado Cancer Center and Nobel-Prize-winning Technion University in Haifa, Israel uses gold nanoparticles to trap and define these molecules in exhaled breath...
19.11.2011 11:00
Merrimack Pharmaceuticals, Inc. announced that the first patient has been dosed in a Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, in combination with erlotinib (Tarceva®), a small molecule directed at the epidermal growth factor receptor (EGFR), in three groups of patients with metastatic non-small cell lung cancer (NSCLC)...
17.11.2011 11:00
Tissue with wound-like conditions allows tumors to grow and spread. In mouse lung cancer cells, treatment with silibinin, a major component of milk thistle, removed the molecular billboards that signal these wound-like conditions and so stopped the spread of these lung cancers, according to a recent study published in the journal Molecular Carcinogenesis...
17.11.2011 10:00
Early screening of patients with chronic obstructive pulmonary disease (COPD) may help to detect lung cancer at an earlier stage, according to a new study. The research, published online in the European Respiratory Journal, suggests that if COPD can be detected at an earlier stage, this will also aid the early detection of lung cancer...
16.11.2011 15:00
According to a new investigation, lung cancer may be detected at an earlier stage by screening individuals with chronic obstructive pulmonary disease (COPD) early. The study suggests that if clinicians can detect COPD at an earlier stage, this will also help to detect lung cancer early. The study is published online today (Nov. 16, 2011) in the European Respiratory Journal...
15.11.2011 20:00
The rise in the number of natural disaster means we cannot consider bonded asbestos as safe anymore, cancer experts in Perth said in the Clinical Oncological Society of Australia's Annual Scientific Meeting...
15.11.2011 11:00
Despite the widespread use of current antiangiogenic cancer therapies, many tumors escape this blockade, which is designed to shut down growth of new blood vessels that feed tumors and spread cancer cells...
Patients with non-small cell lung cancer who have mutations in the KRAS gene should respond well to the antifolate class of drugs, according to results of a recent study conducted by Quintiles comparing human lung cancer cell lines and patients...
13.11.2011 10:00
A new type of therapy aimed at reversing the gene-silencing that promotes cancer-cell growth has shown promising results in a small clinical trial conducted by researchers at the Johns Hopkins Kimmel Cancer Center...
10.11.2011 12:00
Patients with recurrent metastatic non-small cell lung cancer have a morbid prognosis, but a new epigenetic therapy may have potential for this population, according to data published in Cancer Discovery, a journal of the American Association for Cancer Research...
10.11.2011 11:00
Researchers in the United States have shown, for the first time, that it is possible to screen cancer patients for a broad range of cancer-causing genetic mutations as part of normal clinical practice. By identifying patients' individual genotypes within a relatively short time frame, doctors are able to target tumours with the most appropriate therapy...
07.11.2011 16:00
According to Cancer Council Australia, new research shows increased lung cancer rates in Australian women, adding urgency to further de-glamorize tobacco smoking. The research should plead an urgent call for the federal Parliament's passage of plain packaging for tobacco bills...
07.11.2011 11:00
Taxanes are a family of compounds that includes one of the most important cancer drugs ever discovered, Taxol®, among other cancer treatments. But the difficulty producing these complex molecules in the lab has hampered or blocked exploration of the family for further drug leads...
05.11.2011 10:00
It has long been known that cancer cells use nutrients differently than normal cells. In recent years, the rapidly reemerging field of cancer metabolism has shed new light on the ways that cancers use glucose to grow and thrive, demonstrating that manipulation of an enzyme called PKM2 is important to this metabolic process...
04.11.2011 10:00
Mayo Clinic researchers have discovered why measles, perhaps the most contagious viral disease in the world, spreads so quickly. The virus emerges in the trachea of its host, provoking a cough that fills the air with particles ready to infect the next host. The findings may also help in the fight against ovarian, breast and lung cancers...
04.11.2011 03:00
A study published Online First in The Lancet Oncology reveals that patients who suffer from the most common form of lung cancer and whose tumors express high levels of epidermal growth factor receptor (EGFR) tend to benefit more from being treated with cetuximab and have a longer life-expectancy compared with those given chemotherapy alone...
27.10.2011 12:00
In a trial that included more than 150,000 participants, those who underwent annual chest radiographic screening for up to 4 years did not have a significantly lower rate of death from lung cancer compared to participants who were not screened, according to a study in the November 2 issue of JAMA...
26.10.2011 16:00
According to a study in the October 26 issue of JAMA researchers found that CT (computer tomographic) scans utilized for lung cancer screening showed that a significant proportion of current or former male smokers had chronic obstructive pulmonary disease (COPD). The finding suggests that CT scans could be utilized as an additional tool in detecting COPD...
26.10.2011 12:00
Among men who were current or former heavy smokers, undergoing lung cancer screening with computed tomography (CT) scanning identified a substantial proportion who had chronic obstructive pulmonary disease (COPD), suggesting that this method may be helpful as an additional tool in detecting COPD, according to a study in the October 26 issue of JAMA...
25.10.2011 13:00
Higher BMI, consumption of black tea and fruit may protect against lung cancer Heavy alcohol consumption may be linked to a greater risk of developing lung cancer, while higher BMI and increased consumption of black tea and fruit are associated with lower risk of the deadly disease...
25.10.2011 11:00
Detroit Holds Record for Highest Lung Cancer Mortality Rates (#1111771, Tuesday, October 25, 3:00 PM Eastern) Compared with other cities, Detroit has one of the highest mortality rates in the United States for non-small cell lung cancer (NSCLC)...
22.10.2011 22:00
An experimental vaccine, called TG4010, given together with chemotherapy resulted in significantly more progression free survival in patients with advanced lung cancer compared to those on chemotherapy alone, researchers from the Université de Strasbourg in Strasbourg, France, reported in the journal The Lancet Oncology...
17.10.2011 15:00
Lung cancer patients with diabetes tend to live longer than patients without diabetes, according to a new study from Norway due to be published in the November issue of the Journal of Thoracic Oncology...
15.10.2011 11:00
An international effort to replace smoky, inefficient household stoves that people commonly use in lower and middle income countries with clean, affordable, fuel efficient stoves could save nearly 2 million lives each year, according to experts from the National Institutes of Health...
13.10.2011 12:00
Researchers at the University of Colorado Cancer Center have developed a test that identifies key biomarkers in advanced lung cancer that helped reduce the risk of death by 36 percent over a 30- month period in a recent clinical trial. "We are moving from a one-size-fits-all model to more personalized medicine in lung cancer," said University of Colorado School of Medicine Professor Fred R...
Lung cancer patients could receive safer and more efficient treatment through a system being developed by researchers at the University of Strathclyde in Glasgow. The scientists have devised a method for giving drugs by inhalation to patients through a nebuliser, rather than the current approach of intravenous delivery...
12.10.2011 14:00
Data from a Phase II randomized, double-blind, placebo-controlled clinical trial which assessed talactoferrin (an oral immunotherapy) in individuals who had previously received treatment for non-small cell lung cancer (NSCLC) has been published and will appear in the November 1, 2011 print issue of the peer-reviewed medical journal, Journal of Clinical Oncology, Agennix AG ...
07.10.2011 12:00
The prognosis for patients with stage II and III inoperable non-small cell lung cancer (NSCLC) is poor, with only about 15 percent of patients surviving at five years post-treatment for the disease. While new treatment strategies are being intensely studied, timely assessment of their efficacy has proven difficult...
07.10.2011 11:00
Carefully tracking the rate of response of human lung tumors during the first weeks of treatment can predict which cancers will undergo sustained regression, suggests a new study by researchers at the Stanford University School of Medicine...
A study by researchers at the University of California, San Diego School of Medicine may lead to a way to prevent the progression, or induce the regression, of lung injury that results from use of the anti-cancer chemotherapy drug Bleomycin. Pulmonary fibrosis caused by this drug, as well as Idiopathic Pulmonary Fibrosis (IPF) from unknown causes, affect nearly five million people worldwide...
06.10.2011 20:00
Frank Lagerwaard, MD, radiation oncologist at VU University Medical Center in Amsterdam, reported this week in a presentation that patients with Stage I NSCLC who were treated with stereotactic ablative radiotherapy (SABR or SBRT) and who were potentially suitable for an operation, achieved similar tumor control rates to individuals treated with the current surgical standard of care...
06.10.2011 12:00
Advanced imaging with Positron Emission Tomography (PET) scans shows great promise in predicting which patients with inoperable lung cancer have more aggressive tumors and need additional treatment following standard chemotherapy/radiation therapy, according to new research...
05.10.2011 12:00
For patients with non-small cell lung cancer (NSCLC) the accurate determination of the lymph node status before therapy is critical to develop an individualized treatment plan...
Results of new research presented at the American Society of Radiation Oncology (ASTRO) 53rd Annual Meeting this week showed that patients with different types of early stage non-small cell lung cancer (NSCLC) can benefit from treatment with stereotactic body radiosurgery (SBRT)...
04.10.2011 12:00
A higher dose of radiation (74 Gy) does not improve overall survival for non-small cell lung cancer that has spread to the lymph nodes, compared to the standard radiation dose (60 Gy), according to an interim analysis of a late-breaking randomized study presented at the plenary session, October 3, 2011, at the 53rdAnnual Meeting of the American Society for Radiation Oncology (ASTRO)...
29.09.2011 13:00
UCLA researchers who analyzed dozens of previously unexamined internal documents from the tobacco industry say tobacco companies developed "deep and intimate" knowledge about the cancer-causing potential of radioactive alpha particles in cigarette smoke but deliberately kept it from the public for more than four decades...
28.09.2011 19:00
According to a study presented at the European Respiratory Society's Annual Congress in Amsterdam, French researchers discovered that exposure to goats could increase the risk of a certain type of lung cancer, known as pneumonic-type lung adenocarcinoma (P-ADC), which has a weak link to tobacco smoking when compared with other types of the disease...
27.09.2011 12:00
Belgian investigators presented new research at the European Respiratory Society's Annual Congress in Amsterdam. They discovered that a diffusion-weighted MRI scan (a new method of diagnostic imaging) could enable more accurate diagnosis of lung cancer and therefore prevent unnecessary surgery...
26.09.2011 11:00
A new type of diagnostic imaging - which can better differentiate benign lung lesions from those which are cancerous - could be used to prevent unnecessary surgery by enabling more accurate diagnosis of the disease...
Exposure to goats could increase the risk of a certain type of lung cancer, according to French researchers. The study, which was presented at the European Respiratory Society's Annual Congress in Amsterdam , has linked a professional exposure to goats with a distinct subset of lung cancer, known as pneumonic-type lung adenocarcinoma (P-ADC)...
19.09.2011 10:00
When lung cancer strikes, it often spreads silently into more advanced stages before being detected. In a new article published in Nature Nanotechnology, biological engineers and medical scientists at the University of Missouri reveal how their discovery could provide a much earlier warning signal...
14.09.2011 10:00
Researchers at Brigham and Women's Hospital (BWH) have identified a new combination of targeted therapies that, together, may treat two aggressive tumor types that until now have not had effective treatments. These findings are published in Cancer Cell on September 13, 2011. While numerous anti-cancer drugs are being developed, many tumors do not respond to currently available single therapies...
Researchers at Emory University School of Medicine have identified a new type of potential anticancer drug. The compound, named FOBISIN, targets 14-3-3 proteins, important for the runaway growth of cancer cells. The researchers were using X-rays to see how FOBISIN fits into the clamp-shaped 14-3-3 protein structure...
13.09.2011 11:00
Lung cancer is one of the most common and deadly types of cancer. Mouse models of lung cancer recapitulate many features of the human disease and have provided new insight about cancer development, progression and treatment...
If you want to help us build a new RSS feed from existing resources, not the form of an RSS feed published on the Web, you can send us a message. Lay out all the necessary information and your email address, we will keep you informed (e) of the process. Applications clearly out-about will be ignored.
Click on the address to select it. Click copy and then paste it into your preferred reader.